SOME INTERNATIONAL BIOSIMILAR EXPERT SPEAKERS FROM OUR PREVIOUS FORUMS
Shein-Chung CHOW
Professor, Department of Biostatistics and Bioinformatics, Duke University School of Medicine
László ENDRÉNYIProfessor Emeritus of Pharmacology and Biostatistics, University of Toronto; Former President of Canadian Society for Pharmaceutical Scientists
János SZEBENI
Director of the Nanomedicine Research and Education Center, Semmelweis Medical University, Budapest, Professor at University of Miskolc, Dep. of Nanobiotechnology and the Regenerative Medicine, Institute of Theoretical Medicine
Andrea LASLOP
European Regulatory Expert,
Unit Head,
Austrian Medicines and Medical Devices Agency
Bernd JILMA
Vice Chair, Department Clinical Pharmacology, Medical University of Vienna
Helmut SCHÜTZOwner at
BEBAC – Consultancy Services for Bioequivalence and Bioavailability Studies
SOME PROFESSIONAL LECTURES FROM THE PROGRAMS OF THE EVENTS
At the very successful Annual Biosimilars Forum event series clinicians, statisticians and regulatory representatives gathered together from around the world to share with each other their perspectives on this actual topic of research in lectures and informal discussions. Some topics of the last two year’s forums:
2nd Annual Biosimilars Forum – 
OCTOBER, 2017
Lecture examples:
• Scientific factors in biosimilar product development
László ENDRÉNYI, Professor Emeritus of University of Toronto;
• Open issues in the assessment of bioequivalence and biosimilarity
Helmut Schütz, Owner at BEBAC – Consultancy Services
• Regulatory Keynote lecture: 12 years of biosimilars in Europe
Andrea LASLOP, Unit Head, Austrian Medicines and Medical Devices Agency
• Immune side effects of biologicals and nanomedicines
János SZEBENI, Director of the Nanomedicine Research and Education Center
1st Annual Biosimilars Forum – OCTOBER, 2016
Lecture examples:
• Design and analysis of biosimilar studies (3-part course)
Shein-Chung CHOW, Professor, Duke University School of Medicine
• Interchangeability of biological drug products
László TÓTHFALUSI, Associate Professor, Semmelweis University of Budapest and László ENDRÉNYI, Professor Emeritus, University of Toronto;
• The regulator’s view on the totality of evidence for biosimilar
Andrea LASLOP, Unit Head, Austrian Medicines and Medical Devices Agency
• Biosimilar development – a statistical assessor’s perspective
Stephan LEHR, Biostatistician, Austrian Medicines and Medical Devices Agency, President, Viennese Section of IBS
Please watch this short videos with the key lecturers and the organizers of the previous forums summarizing their thoughts about the topic and sharing their experiences. Click on the buttons below to reach more information about the events with photo gallery, video interviews with the key lecturers and account of experiences articles of the events.
ASK OUR EXPERTS IN BIOSIMILARS
Take advantage from the expertise and experience of Accelsiors’ biosimilar team! Combining our proficiency in different therapeutic areas, with tailored service capabilities and fast access to diverse patient populations, Accelsiors can support you in every aspect of clinical and nonclinical development of your biosimilar compound from the concept through pre-clinical development to successful conduct of Phase III registration trials. Don’t hesitate to ask Accelsiors’ Biosimilar Research experts and benefit from our expertise in biosimilars!
Some of 
‘ values provided for your success:
2 decades of experiences in biosimilar clinical trials
World-class
biosimilar knowledge base
Dedicated team of biosimilar experts
Time- and cost efficient solutions to accelerate your program
Global resources
with a flexible local support
Complete range
of expertise tailored for your specific needs
DO YOU NEED MORE PROFESSIONAL HELP?
Feel free to ask ‘ Biosimilar Reserach experts!
Focus with us on the most actual challenges of biosimilar development in 2018 again!
Based on the success of our last year’s professional events, we started to prepare our next, 3rd Annual Biosimilars Forum, planned to be held on the beggining of OCTOBER, 2018 in Budapest. This unique forum will cover important issues again and specific areas of debate facing clinical development teams biosimilars with a strong scientific focus on statistical and regulatory perspectives. The program of the event will be supported and complemented by international subject experts from the biosimilars and nanosimilars area.
It is particularly useful for those who are interested in constructive and open dialogue between medical statisticians, regulatory professionals, clinical researchers and sponsors with whom they collaborate.
<!–
DOWNLOAD FOR FREE all the presentations of
the 2nd Annual Biosimilars Forum
The presentation materials of the professionally very fruitful 2nd Annual Biosimilars Forum are now available in English to download as courtesy of the organizers of the event series. Sign-up for free now to reach your copies!
Discover the program of this professionally very fruitful event!
ABOUT THE ORGANIZERS
The Annual Biosimilars Forum event series was founded in 2016 by two prestigious Central European scientific societies, the Viennese Section of the IBS and the Hungarian Society for Clinical Biostatistics in cooperation with the Accelsiors CRO Ltd., aimed at increasing effectiveness of clinical research and in order to provide even more effective support in sharing of recent scientific and practical knowledge for biosimilar development professionals and provide an opportunity for a constructive and open dialogue between regulatory professionals, clinical researchers, medical statisticians and pharmaceutical developers.
Some of ‘ values provided for your success:
2 decades of experiences in biosimilar clinical trials
Dedicated team of biosimilar experts
Global resources with a flexible local support
World-class biosimilar knowledge base
Time- and cost efficient solutions to accelerate your program
Complete range of expertise tailored for your specific needs
DO YOU NEED MORE PROFESSIONAL HELP?
Feel free to ask ‘ Biosimilar Reserach experts!
